Kintsugi

company

About

Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$20M
Industries
Artificial Intelligence,Biotechnology,Health Care,Health Diagnostics,Machine Learning
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Kintsugi is developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$21.50M
Kintsugi has raised a total of $21.50M in funding over 2 rounds. Their latest funding was raised on Feb 28, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 28, 2022 Series A $20M 1 Detail
May 17, 2021 Grant $1M 1 National Science Foundation Detail
Sep 10, 2020 Grant $256K 1 National Science Foundation Detail
Aug 26, 2019 Grant $249.77K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
2
Kintsugi is funded by 2 investors. National Science Foundation and AngelList Talent are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
AngelList Talent Series A